Renal allograft function in patients with chronic viral hepatitis B and C treated with interferon alpha

Transplant Proc. 1995 Feb;27(1):958-9.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chronic Disease
  • Creatinine / blood
  • Female
  • Follow-Up Studies
  • Graft Survival*
  • HLA-DR Antigens / biosynthesis
  • HLA-DR Antigens / blood
  • Hepatitis B / complications
  • Hepatitis B / therapy*
  • Hepatitis C / complications
  • Hepatitis C / therapy*
  • Humans
  • Interferon Type I / therapeutic use*
  • Kidney Transplantation / immunology
  • Kidney Transplantation / physiology*
  • Male
  • Middle Aged
  • Postoperative Complications / therapy
  • Receptors, Interleukin-2 / analysis
  • Receptors, Interleukin-2 / biosynthesis
  • Recombinant Proteins
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Time Factors
  • Transplantation, Homologous

Substances

  • HLA-DR Antigens
  • Interferon Type I
  • Receptors, Interleukin-2
  • Recombinant Proteins
  • Creatinine